Changes of Oxidative Stress, Glutathione, and Its Dependent Antioxidant Enzyme Activities in Patients with Hepatocellular Carcinoma before and after Tumor Resection

The changes in and relationship between oxidative stress and the glutathione (GSH) antioxidant system in the plasma and tissues of patients with hepatocellular carcinoma (HCC) before and after tumor resection have not been clearly determined. We investigated the changes in oxidative stress, GSH status and its dependent antioxidant enzyme activities in HCC patients before and after tumor resection, and to determine the association of oxidative stress with GSH and its dependent antioxidant enzyme activities in plasma and tissues. This study employed a cross-sectional design. Forty-four men and 16 women with HCC were recruited. Fasting blood was drawn on the day before the tumor resection and one month after the tumor resection. HCC tissue and adjacent normal liver tissue were obtained at the time of surgical resection. Patients had significantly increased plasma malondialdehyde (MDA) and oxidized-low density lipoprotein levels but decreased GSH and oxidized GSH levels before tumor resection compared with the corresponding post-resection values. GSH and trolox equivalent antioxidant capacity (TEAC) levels and activities of GSH peroxidase were significantly increased while MDA level was significantly lower in HCC tissue when compared with the adjacent normal tissue. The pre-resection plasma MDA level was significantly correlated with pre-resection plasma GSH concentration, and MDA level in HCC and adjacent normal tissues. Pre-resection plasma GSH concentration was significantly correlated with GSH and TEAC level in HCC tissue. HCC patients had increased oxidative stress, decreased GSH, and lower dependent antioxidant capacities before tumor resection. However, hepatocellular tumor had increased GSH and TEAC levels as well as GSH peroxidase activities which might protect itself against increased oxidative stress.

[1]  R. Yahya,et al.  Role of interleukin-8 and oxidative stress in patients with hepatocellular carcinoma. , 2013, Clinical laboratory.

[2]  K. Rokutan,et al.  S-thiolation of individual human neutrophil proteins including actin by stimulation of the respiratory burst: evidence against a role for glutathione disulfide. , 1994, Archives of biochemistry and biophysics.

[3]  M. Yin,et al.  B vitamins deficiency and decreased anti-oxidative state in patients with liver cancer , 2007, European journal of nutrition.

[4]  G. Marchesini,et al.  Synthesis of glutathione in response to methionine load in control subjects and in patients with cirrhosis. , 2000, Metabolism: clinical and experimental.

[5]  S. Nagini,et al.  Tissue lipid peroxidation and antioxidant status in patients with adenocarcinoma of the breast. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[6]  I. Fouad,et al.  Glutathione and its metabolizing enzymes in patients with different benign and malignant diseases. , 2000, Clinical biochemistry.

[7]  H. Czeczot,et al.  Glutathione and GSH-dependent enzymes in patients with liver cirrhosis and hepatocellular carcinoma. , 2006, Acta biochimica Polonica.

[8]  C. Sen Cellular thiols and redox-regulated signal transduction. , 2000, Current topics in cellular regulation.

[9]  R. Ricciarelli,et al.  DNA oxidative damage of neoplastic rat liver lesions. , 2010, Oncology reports.

[10]  A. Meister,et al.  Glutathione: interorgan translocation, turnover, and metabolism. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[11]  H. Honda,et al.  Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation. , 2008, AJR. American journal of roentgenology.

[12]  T. Oster,et al.  The glutathione-related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features , 2001, Journal of Cancer Research and Clinical Oncology.

[13]  M. de Kock,et al.  Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[14]  M. Nitti,et al.  Role of Glutathione in Cancer Progression and Chemoresistance , 2013, Oxidative medicine and cellular longevity.

[15]  P. Schirmacher,et al.  Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma , 2004, Hepatology.

[16]  F. García-Cánovas,et al.  Inhibition by L-ascorbic acid and other antioxidants of the 2.2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) oxidation catalyzed by peroxidase: a new approach for determining total antioxidant status of foods. , 1996, Analytical biochemistry.

[17]  J. Estrela,et al.  Glutathione in Cancer Cell Death , 2011, Cancers.

[18]  Shelly C. Lu Regulation of glutathione synthesis. , 2009, Molecular aspects of medicine.

[19]  Hajime Otani,et al.  Erratum to “Site-Specific Antioxidative Therapy for Prevention of Atherosclerosis and Cardiovascular Disease” , 2013, Oxidative Medicine and Cellular Longevity.

[20]  N. Ballatori,et al.  Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes. , 2001, Journal of hepatology.

[21]  Y. Miura,et al.  Potentiation of invasive activity of hepatoma cells by reactive oxygen species is mediated by autocrine/paracrine loop of hepatocyte growth factor. , 2003, Biochemical and biophysical research communications.

[22]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[23]  Szu-Hsien Wu,et al.  Evaluation of redox statuses in patients with hepatitis B virus-associated hepatocellular carcinoma , 2009, Annals of clinical biochemistry.

[24]  Szu-Hsien Wu,et al.  Glutathione status in the blood and tissues of patients with virus-originated hepatocellular carcinoma. , 2007, Clinical biochemistry.

[25]  H. Yang,et al.  Mechanism and Significance of Increased Glutathione Level in Human Hepatocellular Carcinoma and Liver Regeneration Western Blot Analysis of Gcs-hs Nuclear Run-on Transcription Assay Electrophoretic Mobility Shift Assay (emsa) , 2022 .

[26]  Guoyao Wu,et al.  Glutathione metabolism and its implications for health. , 2004, The Journal of nutrition.

[27]  N. Kaplowitz,et al.  Glutathione in liver diseases and hepatotoxicity. , 2009, Molecular aspects of medicine.

[28]  C. Shih,et al.  Differential expression of antioxidant enzymes in various hepatocellular carcinoma cell lines , 2005, Journal of cellular biochemistry.

[29]  G. Marchesini,et al.  Glutathione kinetics in normal man and in patients with liver cirrhosis. , 1997, Journal of hepatology.

[30]  J. Carretero,et al.  Acceleration of Glutathione Efflux and Inhibition of γ-Glutamyltranspeptidase Sensitize Metastatic B16 Melanoma Cells to Endothelium-induced Cytotoxicity* , 2005, Journal of Biological Chemistry.

[31]  F. Cuccurullo,et al.  Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. , 2001, Free radical biology & medicine.